Healthcare AI company Innovaccer announced on Wednesday that it is committing $250 million over the next three years to build out its platform of AI agents, which perform tasks across
New Bill Seeks to Lower Out-of-Pocket Drug Costs
Rep. Greg Murphy (R-North Carolina) introduced the Every Dollar Counts Act on Tuesday. It would ensure out-of-pocket costs for covered prescription drugs are applied toward patients’ deductibles and maximum out-of-pocket
Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors
Antibody drug conjugates continue to be a robust area for research and dealmaking, and Eli Lilly’s latest move in this space is the acquisition of CrossBridge Bio, a preclinical startup
Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft
AI-powered cardiac imaging company HeartFlow sued its competitor Cleerly this week, claiming the company infringed on its patents and misused proprietary technology to build a competing platform. The lawsuit, filed
Vida Health Teams Up with ŌURA to Provide More Personalized Metabolic Care
Vida Health, a virtual cardiometabolic care provider, is partnering with wearable device company ŌURA to integrate ŌURA’s biometric data into Vida’s clinical programs, the companies announced on Tuesday. Vida offers
Why Synthetic Data is the Antidote to Clinical Trials
Medical device innovation is laborious because of the high bar for validating that the technology does no harm. Patient recruitment for statistically powered trials stretches timelines and drives validation costs
Report: Growth in MA Is Associated With Lower Total Medicare Spending
Enrollment in Medicare Advantage has steadily increased over the past two decades. The number of MA enrollees grew from about 11 million (25% of total Medicare beneficiaries) in 2010 to
Hospital Margins Squeeze as Costs Outpace Revenue Growth
Hospitals’ financial positioning is somewhat stable but still under significant pressure, mainly from rising costs and reimbursement issues, according to data released last week by Kaufman Hall. The consulting firm
The AI Value Gap and Why Validation is a Practical First Win for Life Sciences
In life sciences, AI usually makes headlines for drug discovery, molecule design or clinical insights. Behind the scenes, though, the fastest and most repeatable wins are showing up in FDA-oriented
‘A Significant Assault on Our Health’: Healthcare Policy Leaders Condemn Trump’s Budget Proposal
To some, President Donald Trump’s budget proposal might be adding an insult to an injury. Last year, the federal government made significant cuts to healthcare coverage in Medicaid via the









